GRAIL Will Be Listed And Commence Regular-Way Trading On The Nasdaq Under The Symbol "GRAL" As Of June 25, 2024.
Portfolio Pulse from Benzinga Newsdesk
GRAIL, Inc. (NASDAQ:GRAL) will commence regular-way trading on the Nasdaq Global Select Market starting June 25, 2024, following its spin-off from Illumina (NASDAQ:ILMN). GRAIL focuses on developing groundbreaking cancer screening technology.
June 24, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GRAIL, Inc. will begin trading on Nasdaq under the symbol 'GRAL' on June 25, 2024, following its spin-off from Illumina. The company is focused on innovative cancer screening technology.
The commencement of trading on Nasdaq is a significant milestone for GRAIL, indicating its transition to a publicly traded company. This event is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEUTRAL IMPACT
Illumina (NASDAQ:ILMN) has completed the spin-off of GRAIL, which will now trade independently on Nasdaq. This move allows Illumina to focus on its core genomics business.
The spin-off of GRAIL allows Illumina to concentrate on its primary genomics business. While this is a strategic move, the immediate impact on Illumina's stock price is likely to be neutral as the market adjusts to the new structure.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70